Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Dr. Kim is a Professor of Neurosurgery at The University of Texas MD Anderson Cancer Center. After completing her medical degree from McMaster University, she completed her PhD in Biomaterials and Biomedical Engineering and Clinical Residency in Neurosurgery from the University of Toronto, and Clinical Fellowships in Skull-Base Surgery from MD Anderson Cancer Center. In 2012, she was named Fellow of The Royal College of Physicians of Canada. Dr. Kim’s clinical practice focuses on the management of primary and secondary central nervous system tumors. As a physician-scientist, she uses a multidisciplinary approach to develop novel and effective therapies that boost the functions of innate immune system to eliminate diseases such as cancer. Applying state-of-art tools in material engineering, optical imaging and protein engineering, Dr. Kim’s lab is studying how materials can be designed to facilitate the recognition and clearance of diseased cells by the body’s immune system as well as novel drug delivery platforms.
Dr. Kim’s research has been funded by multiple R01 grants from the National Institutes of Health (NIH) and the Department of Defense. Her studies have been published in Nature, Nature Nanotechnology, Nature Biomedical Engineering, Nature Communications and the New England Journal of Medicine among others. Dr. Kim is an elected fellow of the American Institute for Medical and Biological Engineering (AIMBE) and the American Society for Clinical Investigation (ASCI).
